IRTC
iRhythm Holdings, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
iRhythm Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Largest filed tie
24.00%
of IRTC revenue · the Medicare program through CMS
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; of iRhythm Holdings, Inc.'s 6 closest co-movers, 2 share that code.
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; of iRhythm Holdings, Inc.'s 6 closest co-movers, 2 share that code.
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Expected move
Inputsspot 126.37exp Nov 20ATM strike 125ATM straddle 13.25IV 61%
No thesis.
Annual filing, covered
10-K parsed · Feb 19 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 19 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
iRhythm Technologies, Inc.
134.76
+8.39 · +6.64%
post 134.76 0.00%
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $355.1M | 8.36% | +8.91% |
| RTW | $259.6M | 6.11% | +30.81% |
| Vanguard Portfolioindex-like | $227.7M | 5.36% | +6.55% |
| Artisan Partners Limited Partnership | $197.5M | 4.65% | +14.43% |
| Vanguardindex-like | $174.0M | 4.10% | +1.21% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $355.1M | 8.36% | +8.91% |
| RTW | $259.6M | 6.11% | +30.81% |
| Vanguard Portfolioindex-like | $227.7M | 5.36% | +6.55% |
| Artisan Partners Limited Partnership | $197.5M | 4.65% | +14.43% |
| Vanguardindex-like | $174.0M | 4.10% | +1.21% |
Bull3
Bear1